Sun Pharma

Decitabine

Manufacturer:

Sun Pharma

Decitabine HCPCS:

J0893

HCPCS Code Descriptor:

Injection, decitabine (sun pharma) not therapeutically equivalent to j0894, 1 mg

Category:

J Code

Decitabine NDCs:

47335-0361-41

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

47335-0361-41

About Decitabine:

Decitabine is an Oncology drug manufactured by Sun Pharma and administered via the Intravenous route of administration. The J Code: J0893 is aligned to the drug Decitabine.

ACCESS PRICING AND MORE BY REGISTERING

J0893 Added Date:

January 1, 2023

J0893 Effective Date:

January 1, 2023

J0893 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Decitabine billing and coding information.
Decitabine patient assistance information can be found through Taiho Patient Support at the URL: https://www.taihopatientsupport.com/
Decitabine prescribing information can be found at the link below:
Information regarding Decitabine’s side effects can be found at MedlinePlus